Ding P - Search Results

1

TCMAnalyzer: A Chemo- and Bioinformatics Web Service for Analyzing Traditional Chinese Medicine.

Liu Z, Du J, Yan X, Zhong J, Cui L, Lin J, Zeng L, Ding P, Chen P, Zhou X, Zhou H, Gu Q, Xu J. Liu Z, et al. Among authors: ding p. J Chem Inf Model. 2018 Mar 26;58(3):550-555. doi: 10.1021/acs.jcim.7b00549. Epub 2018 Mar 1. J Chem Inf Model. 2018. PMID: 29420025

2

Structurally Selective Mechanism of Liver X Receptor Ligand: In Silico and In Vitro Studies.

Ding P, Chen Z, Chen H, Zhang Z, Liu Z, Yan X, Zhou H, Gu Q, Li C, Xu J. Ding P, et al. J Chem Inf Model. 2019 Jul 22;59(7):3277-3290. doi: 10.1021/acs.jcim.9b00292. Epub 2019 Jun 26. J Chem Inf Model. 2019. PMID: 31192592

3

ASDB: a resource for probing protein functions with small molecules.

Liu Z, Ding P, Yan X, Zheng M, Zhou H, Xu Y, Du Y, Gu Q, Xu J. Liu Z, et al. Among authors: ding p. Bioinformatics. 2016 Jun 1;32(11):1752-4. doi: 10.1093/bioinformatics/btw055. Epub 2016 Jan 28. Bioinformatics. 2016. PMID: 26822210

4

The Mechanisms of Bushen-Yizhi Formula as a Therapeutic Agent against Alzheimer's Disease.

Cai H, Luo Y, Yan X, Ding P, Huang Y, Fang S, Zhang R, Chen Y, Guo Z, Fang J, Wang Q, Xu J. Cai H, et al. Among authors: ding p. Sci Rep. 2018 Feb 15;8(1):3104. doi: 10.1038/s41598-018-21468-w. Sci Rep. 2018. PMID: 29449587 Free PMC article.

5

Identify liver X receptor β modulator building blocks by developing a fluorescence polarization-based competition assay.

Zhang Z, Chen H, Chen Z, Ding P, Ju Y, Gu Q, Xu J, Zhou H. Zhang Z, et al. Among authors: ding p. Eur J Med Chem. 2019 Sep 15;178:458-467. doi: 10.1016/j.ejmech.2019.06.011. Epub 2019 Jun 10. Eur J Med Chem. 2019. PMID: 31202993

6

PTS: a pharmaceutical target seeker.

Ding P, Yan X, Liu Z, Du J, Du Y, Lu Y, Wu D, Xu Y, Zhou H, Gu Q, Xu J. Ding P, et al. Database (Oxford). 2017 Jan 1;2017:bax095. doi: 10.1093/database/bax095. Database (Oxford). 2017. PMID: 31725865 Free PMC article.

7

Discovery of a New Pterocarpan-Type Antineuroinflammatory Compound from Sophora tonkinensis through Suppression of the TLR4/NFκB/MAPK Signaling Pathway with PU.1 as a Potential Target.

Xia W, Luo P, Hua P, Ding P, Li C, Xu J, Zhou H, Gu Q. Xia W, et al. Among authors: ding p. ACS Chem Neurosci. 2019 Jan 16;10(1):295-303. doi: 10.1021/acschemneuro.8b00243. Epub 2018 Sep 28. ACS Chem Neurosci. 2019. PMID: 30223643

8

Discovery of new LXRβ agonists as glioblastoma inhibitors.

Chen H, Chen Z, Zhang Z, Li Y, Zhang S, Jiang F, Wei J, Ding P, Zhou H, Gu Q, Xu J. Chen H, et al. Among authors: ding p. Eur J Med Chem. 2020 May 15;194:112240. doi: 10.1016/j.ejmech.2020.112240. Epub 2020 Mar 17. Eur J Med Chem. 2020. PMID: 32248003

9

Discovery of novel liver X receptor inverse agonists as lipogenesis inhibitors.

Chen Z, Chen H, Zhang Z, Ding P, Yan X, Li Y, Zhang S, Gu Q, Zhou H, Xu J. Chen Z, et al. Among authors: ding p. Eur J Med Chem. 2020 Nov 15;206:112793. doi: 10.1016/j.ejmech.2020.112793. Epub 2020 Sep 6. Eur J Med Chem. 2020. PMID: 32961480

10

Structural insights into the ligand recognition and catalysis of the key aminobutanoyltransferase CntL in staphylopine biosynthesis.

Luo Z, Luo S, Ju Y, Ding P, Xu J, Gu Q, Zhou H. Luo Z, et al. Among authors: ding p. FASEB J. 2021 May;35(5):e21575. doi: 10.1096/fj.202002287RR. FASEB J. 2021. PMID: 33826776

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,841 results

Search Page